| Total (n = 79) | Malignant (n = 65) | Benign (n = 14) | P a |
---|---|---|---|---|
Age (years) | 68.59 ± 12.02 | 69.15 ± 11.15 | 66.00 ± 15.66 | 0.376 |
Sex (male to female) | 53:26 | 44:21 | 9:5 | 0.806 |
Chief complaint | Â | Â | Â | Â |
 Jaundice | 52 (66 %) | 44 (68 %) | 8 (57 %) | 0.450 |
 Pain | 3 (4 %) | 2 (3 %) | 1 (7 %) | 0.470 |
 Cholangitis | 19 (24 %) | 15 (19 %) | 4 (29 %) | 0.663 |
 Stent exchange | 2 (3 %) | 2 (3 %) | 0 (0 %) | 0.506 |
 CBD dilatation | 2 (3 %) | 1 (2 %) | 1 (7 %) | 0.226 |
 Pancreatitis | 1 (1 %) | 1 (2 %) | 0 (0 %) | 0.640 |
Total bilirubin (mg/dL) | 8.43 ± 6.33 | 9.14 ± 6.47 | 4.87 ± 4.18 | 0.025* |
CEA (ng/mL) | 18.90 ± 57.73 | 20.58 ± 60.95 | 6.08 ± 9.78 | 0.566 |
CA 19-9 (U/mL) | 1863.70 ± 5062.73 | 2122.58 ± 5736.81 | 88.54 ± 75.95 | 0.325 |
ALKP (U/L) | 365.65 ± 320.33 | 367.86 ± 322.48 | 352.80 ± 324.09 | 0.892 |
Stricture level (CBD:CHD) | 54:25 | 42:23 | 12:2 | 0.124 |